Headlined by Riteish Deshmukh and created by Raj Kumar Gupta, Pill is an important watch as it explores the dark side of the Indian pharmacuetical industry.
The pharmaceutical giant said clinical evaluation of once-daily doses its oral GLP-1 agonist candidate danuglipron demonstrated "encouraging" data. Dose optimization studies are planned.
Pfizer plans to move a reworked, once-a-day version of its weight-loss pill danuglipron into clinical trials later this year, the company said on Thursday.
Apple recently reintroduced the with a new, redesigned and improved model. And to promote the product’s comeback, the company also brought back the classic Beats campaign starring the Beats Pill Characters, also known as the “Beats Pill…
When Texas tried in the past to get its hands on pentobarbital, a drug used in lethal injections there to mixed success, pharmaceutical companies said they wanted no part of the execution circuit. The state apparently found another conduit…
Pfizer announced Thursday plans to move forward with an oral daily weight loss medication in the same drug category as treatments including Ozempic and Zepbound. The pharmaceutical giant said clinical evaluation of once-daily doses its…
Novo Nordisk, Eli Lilly and Pfizer are developing weight loss pills. Meanwhile, digital health funding shows 'measured momentum' this year, a report said.
Dozens of kids and teenagers shouted anti-drug slogans at motorists and spoke with pedestrian passersby in Dover, N.H., on Wednesday as part of a public awareness campaign about the dangers of counterfeit pills.
Pfizer announced that it is advancing its oral weight-loss treatment, called danuglipron, to the next round in an ongoing study after seeing "encouraging" results.
Record producer and songwriter Glen Ballard’s philosophy about making music has served him well over the last four decades, winning him six Grammy Awards, a place in the Songwriters Hall of Fame, and, on July 11, a star on the Hollywood…
On Thursday, Pfizer Inc. (NYSE:PFE) announced that, based on results from the ongoing Phase 1 pharmacokinetic study, it has selected its preferred once-daily modified release formulation for danuglipron, an oral glucagon-like peptide-1 …